Vaxxinity Email Formats

Biotechnology Research • Merritt Island, Florida, United States • 21-50 Employees

Vaxxinity Email Formats

Vaxxinity uses 3 email formats. The most common is {first name} (e.g., john@vaxxinity.com), used 44.4% of the time.

Format	Example	Percentage
{first name}	john@vaxxinity.com	44.4%
{first initial}	j@vaxxinity.com	33.3%
{last name}	doe@vaxxinity.com	22.2%

Key Contacts at Vaxxinity

Peter H. Diamandis

Co-Founder And Vice-Chairman

James Alansmith

Member Board Of Directors

Lewis Yim

Director, Technology & Infrastructure

Shuang Ding

Director, Bioassay & Biomarker

Max Fox

Co-Founder And Vice-Chairman

Sam Chan

Financial Director

Company overview

Headquarters	505 Odyssey Way, Exploration Park, Cape Canaveral, Florida 32953, US
Phone number	+12542445739
Website	vaxxinity.com
NAICS	541714
SIC	873
Employees	21-50
Socials

About Vaxxinity

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.